image
Healthcare - Biotechnology - NASDAQ - US
$ 2.41
-16.6 %
$ 112 M
Market Cap
-1.16
P/E
BALANCE SHEET
118 M ASSETS
-16.45%
46.1 M LIABILITIES
87.17%
71.6 M EQUITY
-38.38%
BALANCE SHEET DECOMPOSITION
Balance Sheet Vigil Neuroscience, Inc.
image
Current Assets 101 M
Cash & Short-Term Investments 97.8 M
Receivables 0
Other Current Assets 2.79 M
Non-Current Assets 17.1 M
Long-Term Investments 0
PP&E 16.1 M
Other Non-Current Assets 1.02 M
83.09 %13.67 %Total Assets$117.7m
Current Liabilities 34.1 M
Accounts Payable 1.97 M
Short-Term Debt 1.04 M
Other Current Liabilities 31.1 M
Non-Current Liabilities 11.9 M
Long-Term Debt 0
Other Non-Current Liabilities 11.9 M
4.27 %67.62 %25.86 %Total Liabilities$46.1m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020
ASSETS
Cash & Cash Equivalents 39.0 52.0 186.6 91.4 24.2
Short Term Investments 58.8 65.9 0 0 0
Receivables 0 1.5 0 0 0
Inventory 0 0 10.6 0 0
Other Current Assets 2.2 2.5 11.2 6.1 1.1
Total Current Assets 100.6 121.9 197.8 97.5 25.3
PP&E 16.1 17.9 1.4 1.3 0
Intangible Assets 0 0 0 0 0
Goodwill 0 0 0 0 0
Long Term Investments 0 0 0.9 0 0
Other Long Term Assets 1.0 1.0 0.3 3.7 0
Other Assets 0 0 0 0 0
Total Assets 117.7 140.9 200.4 102.4 25.3
LIABILITIES
Accounts Payable 2.0 1.9 1.9 4.0 1.1
Short Term Debt 1.0 0.9 0.4 1.7 0
Other Current Liabilities 31.1 8.8 9.0 4.2 0.9
Total Current Liabilities 34.1 11.7 11.3 9.9 2.0
Long Term Debt 0 12.9 0 64 K 303
Deferred Tax Income 0 0 0 0 0
Other Liabilities 0 0 0 161.9 51.6
Total Liabilities 46.1 24.6 11.3 171.9 53.6
EQUITY
Common Stock 4 K 4 K 4 K 0 0
Retained Earnings (307.0) (222.8) (140.1) (71.8) (28.5)
Other Accumulative Comprehensive Income/Loss 27 K 5 K 0 0 0
Total Equity 71.6 116.3 189.1 (69.4) (28.3)
Total Liabilities and Equity 117.7 140.9 200.4 102.4 25.3
SHARES OUTSTANDING
Common Shares Outstanding 40.7 38.7 31.7 1.5 28.3